| Literature DB >> 35402543 |
Shengyu Bi1, Fenglin Jia1, Chang Lv1, Qiang He2, Xinyu Xu1, Zhixiao Xue1, Siying Su3.
Abstract
Pulsed field ablation (PFA) is a novel method of pulmonary venous isolation in atrial fibrillation ablation and is featured by tissue-selective ablation. Isolation is achieved via the application of high-voltage microsecond pulses that create irreversible perforations in cell membranes (i.e., electroporation). We proposed a new biphasic asymmetric pulse mode and verified the lesion persistence and safety of this mode for pulmonary vein ostia ablation in preclinical studies. We found that biphasic asymmetric pulses can effectively reduce muscle contractions and drop ablation threshold. In the electroanatomic mapping, the ablation site showed a continuous low potential area, and the atrium was not captured after 30 days of pacing. Pathological staining showed that cardiomyocytes in the ablation area were replaced by fibroblasts and there was no damage outside the ablation zone. Our results show that pulmonary venous isolation using the biphasic asymmetric discharge mode is safe, durable, effective, and causes no damage to other tissues.Entities:
Keywords: atrial fibrillation; biphasic asymmetric pulse; pulmonary venous isolation; pulsed field ablation; tissue-selective ablation
Year: 2022 PMID: 35402543 PMCID: PMC8987372 DOI: 10.3389/fcvm.2022.859480
Source DB: PubMed Journal: Front Cardiovasc Med ISSN: 2297-055X
Figure 1Pulsed field ablation system. (A) Biphasic asymmetric pulsed field ablation catheter in open state. (B) Illustration of the front end of the ablation catheter. Arrow a is the positioning electrode. Arrow b refers to the catheter frame. The white dotted box represents the electrode. (C) Left superior pulmonary angiography. Yellow dotted line marking the contour. (D) Pacing after ablation. (E) PFA catheter for ablation at the left superior pulmonary vein ostia. PFA catheter shape shown in yellow dotted circle. (F) Pulsed field ablation mode. Mode c is biphasic asymmetric pulsed field ablation.
Procedural characteristics of biphasic asymmetric PFA.
|
|
|
|
|---|---|---|
| PFA Times, median (sec) | 81.6 (73.7, 94.3) | 71.9 (71.0, 72.8) |
| Peak current, average (Amp) ±SD | 7.83 ± 1.90 | 7.10 ± 0.42 |
| Therapy dose (V, Voltage) | 1,000 V | 1,000 V |
| Procedure time, median (minutes) | 95 (88, 104.5) | 81.5 (80.75, 82.25) |
PFA Times data are presented as median (25th, 75th percentiles).
Procedure time data are presented as median (25th, 75th percentiles).
PFA, pulsed field ablation; sec, second; Amp, ampere; SD, Standard Deviation.
Figure 2Electroanatomic modeling of the right superior pulmonary vein. (A) Baseline potentials in right superior pulmonary were assessed. The yellow dotted line draws the right superior pulmonary vein ostia. (B) Post-operative ablation site shows a low potential area. (C) Pulmonary vein electrograms from PFA catheter ablation. Left: Pre-ablation. Right: Post-ablation. (D) Right superior pulmonary vein potential after 30 days. Continuous low potential in the ablation zone. The color of the mapping from red to purple indicates the potential from low to high. EnSite, Abbott: (A–C). Carto3, Johnson & Johnson: (D).
Figure 3Pathological changes of myocardial tissues after PFA ablation. (A) Gross observation of the left superior pulmonary vein ablation site. In the control group, lesion areas were not seen. The 7- and 30-day groups (group A and B) show a clear ablation zone. (B) HE staining of ablation sites at 100X and 400X. a indicates myocardial tissue. b represents intimal layer (endothelium, fibroblasts and connective tissue). c is marked with adventitia. (C) Masson staining of ablation sites (40X). Control group, days 7 and 30 from left to right.
Pathology summary of Group A and B.
|
|
|
|
|
|---|---|---|---|
| Number of ablated locations ( | 6 | 6 | – |
| Targeted anatomical location | LSPV | LSPV | – |
| Euthanasia (d, days) | 7 d | 30 d | – |
| Transmurally achieved | 6/6 | 6/6 | – |
| Wall thickness of ablated tissue, average (mm) ± SD | 0.68 ± 0.24 | 0.60 ± 0.27 | 0.589 |
| Thickness of Cf, average (mm) ± SD | 0.68 ± 0.24 | 0.096 ± 0.03 | 0.002 |
| Depth of Cf (median, %) | 100.00% | 18.30% | 0.002 |
| Other lesions | 0/6 | 0/6 | – |
P-values were shown for the Mann-Whitney U-test.
LSPV, left superior pulmonary vein; RSPV, right superior pulmonary vein; Cf, collagen fibers.
The total wall thickness in the control group was 0.88 ± 0.02 (average ± SD).
The collagen fiber thickness in the control group was 0.11 ± 0.04 (average ± SD).
Comparisons for percentages of the collagen fiber depth over total thickness.
|
|
|
|
|---|---|---|
|
| ||
| Group A ( | 100% (100%, 100%) | 0.002 |
| Control A ( | 13.27% (11.28%, 14.95%) | |
|
| ||
| Group B ( | 18.30% (13.68%, 20.14%) | 0.699 |
| Control B ( | 16.01% (11.30%, 19.04%) | |
Depth Percentage means the percentages of the collagen fiber depth over total thickness, and they are presented as median (the 25th percentile, the 75th percentile).